Tag Archives: AUPH

The Chief Business Officer of Aurinia Pharmaceuticals (NASDAQ: AUPH) is Selling Shares

Yesterday, the Chief Business Officer of Aurinia Pharmaceuticals (AUPH – Research Report), Michael Robert Martin, sold shares of AUPH for $68.8K. See today’s analyst top recommended stocks >> Based on Aurinia Pharmaceuticals’ latest earnings report for the quarter ending March

Analysts Are Bullish on Top Healthcare Stocks: Aurinia Pharmaceuticals (AUPH), X4 Pharmaceuticals (XFOR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aurinia Pharmaceuticals (AUPH – Research Report) and X4 Pharmaceuticals (XFOR – Research Report) with bullish sentiments. Aurinia Pharmaceuticals (AUPH) Oppenheimer analyst Justin

Leerink Partners Thinks Aurinia Pharmaceuticals’ Stock is Going to Recover

Leerink Partners analyst Joseph Schwartz maintained a Buy rating on Aurinia Pharmaceuticals (AUPH – Research Report) on April 8. The company’s shares closed last Friday at $12.80, close to its 52-week low of $12.01. According to TipRanks.com, Schwartz is a

The Chairman of Aurinia Pharmaceuticals (NASDAQ: AUPH) is Buying Shares

Yesterday, the Chairman of Aurinia Pharmaceuticals (AUPH – Research Report), George M Milne, bought shares of AUPH for $65K. This recent transaction increases George M Milne’s holding in the company by 13% to a total of $590.4K. In addition to

The Non-Executive of Aurinia Pharmaceuticals (NASDAQ: AUPH) is Buying Shares

Today, the Non-Executive of Aurinia Pharmaceuticals (AUPH – Research Report), Jill Diane Leversage, bought shares of AUPH for $42.3K. In addition to Jill Diane Leversage, 2 other AUPH executives reported Buy trades in the last month. Following Jill Diane Leversage’s

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (NASDAQ: AUPH) and ADMA Biologics (NASDAQ: ADMA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aurinia Pharmaceuticals (AUPH – Research Report) and ADMA Biologics (ADMA – Research Report) with bullish sentiments. Aurinia Pharmaceuticals (AUPH) H.C. Wainwright analyst